Dapagliflozin
2 stories
-
healthDiabetes Drug Dapagliflozin Slashes Heart Failure Risk in Genetic Carriers
Harvard, MIT, and Mass General Brigham researchers reveal dapagliflozin dramatically reduces heart failure hospitalizations in patients with inherited cardiomyopathy variants, marking a major step in precision preventive cardiology.
-
healthNew Study Challenges Kidney Function Estimates, Citing Ethnic Disparities
UK study reveals widely used eGFR equations misclassify kidney function, impacting diagnosis and treatment, especially for minority groups.